关键信息
-
基因名
SV2A
- 应用
-
别名
SV2A；KIAA0736；Synaptic vesicle glycoProtein 2A
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q7L0J3
-
表达区间
1-742aa
-
氨基酸序列
MEEGFRDRAAFIRGAKDIAKEVKKHAAKKVVKGLDRVQDEYSRRSYSRFEEEDDDDDFPAPSDGYYRGEGTQDEEEGGASSDATEGHDEDDEIYEGEYQGIPRAESGGKGERMADGAPLAGVRGGLSDGEGPPGGRGEAQRRKEREELAQQYEAILRECGHGRFQWTLYFVLGLALMADGVEVFVVGFVLPSAEKDMCLSDSNKGMLGLIVYLGMMVGAFLWGGLADRLGRRQCLLISLSVNSVFAFFSSFVQGYGTFLFCRLLSGVGIGGSIPIVFSYFSEFLAQEKRGEHLSWLCMFWMIGGVYAAAMAWAIIPHYGWSFQMGSAYQFHSWRVFVLVCAFPSVFAIGALTTQPESPRFFLENGKHDEAWMVLKQVHDTNMRAKGHPERVFSVTHIKTIHQEDELIEIQSDTGTWYQRWGVRALSLGGQVWGNFLSCFGPEYRRITLMMMGVWFTMSFSYYGLTVWFPDMIRHLQAVDYASRTKVFPGERVEHVTFNFTLENQIHRGGQYFNDKFIGLRLKSVSFEDSLFEECYFEDVTSSNTFFRNCTFINTVFYNTDLFEYKFVNSRLINSTFLHNKEGCPLDVTGTGEGAYMVYFVSFLGTLAVLPGNIVSALLMDKIGRLRMLAGSSVMSCVSCFFLSFGNSESAMIALLCLFGGVSIASWNALDVLTVELYPSDKRTTAFGFLNALCKLAAVLGISIFTSFVGITKAAPILFASAALALGSSLALKLPETRGQVLQ
-
分子量
82.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
The SV2A protein, also known as synaptic vesicle glycoprotein 2A, is a critical component of the synaptic vesicle membrane in neurons, playing a fundamental role in neurotransmitter release. Its importance in synaptic transmission has garnered significant interest in both neuroscience and pharmacology, particularly due to its involvement in synaptic plasticity and neurological disorders. Research has shown that SV2A is essential for the proper functioning of synapses, influencing the efficacy of synaptic transmission and affecting various cognitive functions. Importantly, SV2A serves as the primary binding site for several antiepileptic drugs, such as levetiracetam, which highlights its therapeutic relevance. The study of SV2A's structure and function, especially through recombinant protein technologies, aids in elucidating its role in synaptic communication and the potential mechanisms underlying neurological disorders. Understanding SV2A at the molecular level may pave the way for novel therapeutic strategies for conditions like epilepsy, schizophrenia, and other synaptic dysfunctions, making it a focal point in ongoing research aimed at addressing pervasive neurological challenges. As scientists continue to explore the nuances of SV2A, the insights gained from recombinant studies will inform both basic neuroscience and the development of new pharmacological agents targeting synaptic processes.
